mercaptopurine (Par Pharmaceutical Inc.)
Welcome to the PulseAid listing for the mercaptopurine drug offered from Par Pharmaceutical Inc.. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Par Pharmaceutical Inc. |
NON-PROPRIETARY NAME: | mercaptopurine |
SUBSTANCE NAME: | MERCAPTOPURINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2004-02-11 |
END MARKETING DATE: | 0000-00-00 |
mercaptopurine HUMAN PRESCRIPTION DRUG Details:
Item Description | mercaptopurine from Par Pharmaceutical Inc. |
LABELER NAME: | Par Pharmaceutical Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(mg/1) |
START MARKETING DATE: | 2004-02-11 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 49884-922_4d29e7e8-7d71-403f-aae1-ea79e1e0e0ef |
PRODUCT NDC: | 49884-922 |
APPLICATION NUMBER: | ANDA040461 |
Other MERCAPTOPURINE Pharmaceutical Manufacturers / Labelers: